Cancer Treatment News and Research

RSS

SU2C and Farrah Fawcett announce formation of research team dedicated to HPV-related cancers

Stand Up To Cancer (SU2C) and the Farrah Fawcett Foundation, along with the American Association for Cancer Research (AACR), SU2C's Scientific Partner, announced the formation of a research team dedicated to HPV-related cancers during a press event today at the AACR Annual Meeting 2014, held here April 5-9.

8 Apr 2014

Magnetic nanoparticle (mNP) hyperthermia in breast cancer treatment

In a presentation exploring the promise of magnetic nanoparticle (mNP) hyperthermia in breast cancer treatment, Dartmouth researcher P. Jack Hoopes, DMV, PhD, reviewed preclinical studies conducted at Norris Cotton Cancer Center and discuss plans for early-phase clinical studies in humans at the annual meeting of the American Association for Cancer Research (AACR).

8 Apr 2014

Women who had radiotherapy for breast cancer may have increased risk of lung tumour

Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue.

7 Apr 2014

Staying disease-free improves dramatically for ovarian cancer patients

The probability of staying disease-free improves dramatically for ovarian cancer patients who already have been disease-free for a period of time, and time elapsed since remission should be taken into account when making follow-up care decisions, according to a study led by researchers at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.

7 Apr 2014

BMC joins SCCA Network, becomes tenth affiliate in the greater Northwest

Bend Memorial Clinic (BMC) has joined the Seattle Cancer Care Alliance (SCCA) Network to become its tenth affiliate in the greater Northwest. The affiliation will expand local access to cancer treatment options and help foster advances in cancer care.

4 Apr 2014

Concord Medical to establish cancer hospital in Shanghai New Hongqiao International Medical Center

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced the Company will establish Shanghai Concord Cancer Hospital ("Shanghai Concord") - a premium cancer hospital - in Shanghai New Hongqiao International Medical Center.

4 Apr 2014

Magnetically controlled nanoparticles force tumour cells to 'self-destruct', shows research

Using magnetically controlled nanoparticles to force tumour cells to 'self-destruct' sounds like science fiction, but could be a future part of cancer treatment, according to research from Lund University in Sweden.

4 Apr 2014

Surgeons use Cyberknife robotic device for treatment of vocal cord cancer

Stephen Wiley, a lifelong cowboy from Terrell, has helped UT Southwestern Medical Center pioneer a new treatment for vocal cord cancer. Mr. Wiley volunteered to be the world's first known patient to be treated for vocal cord cancer with Cyberknife, a surgeon-controlled robotic device that destroys tumors with highly precise doses of radiation.

4 Apr 2014

Inhibiting cancer-promoting prolactin causes unconventional cell death in preclinical research

Under stress from chemotherapy or radiation, some cancer cells dodge death by consuming a bit of themselves, allowing them to essentially sleep through treatment and later awaken as tougher, resistant disease.

4 Apr 2014

Scientists battle against cancer with nanoballoons and lasers

Chemotherapeutic drugs excel at fighting cancer, but they're not so efficient at getting where they need to go.

4 Apr 2014

Dartmouth aims to remove barriers for pancreatic cancer photodynamic therapy

Using CT scans with contrast enhancement, Dartmouth researchers measured treatment response to pancreatic cancer photodynamic therapy (PDT) according to a paper published in Physics in Medicine and Biology.

3 Apr 2014

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Otsuka Pharmaceutical Co., Ltd. has announced an agreement with Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. to acquire rights to the hematological cancer treatment Dacogen and to an enzyme inhibitor, E7727.

31 Mar 2014

MD Anderson's Jim Allison honored with 2014 Canada Gairdner International Award

A Canadian institution that annually recognizes seminal medical discoveries selected cancer immunotherapy leader Jim Allison, Ph.D., chair and professor of Immunology at The University of Texas MD Anderson Cancer Center, for one of its 2014 Canada Gairdner International Awards.

29 Mar 2014

Study: Sexual dysfunction common with lung cancer

Many lung cancer patients suffer difficulties with sexual expression and intimacy, yet for too long the topic has been ignored by doctors and researchers, experts have said at the 4th European Lung Cancer Conference (ELCC).

28 Mar 2014

Journal addresses impact of obesity on gynecologic cancer patients

Latest special issue of journal Gynecologic Oncology addresses the impact of obesity on gynecologic cancer patients, oncologists and cancer care delivery systems

26 Mar 2014

Adaptimmune awarded £2.1 million grant to expedite development of engineered T cell therapy

Adaptimmune today announced that it has been awarded a grant of £2.1 million from the Biomedical Catalyst Fund, managed by the UK’s innovation agency the Technology Strategy Board and the Medical Research Council. The prestigious award will expedite the development of Adaptimmune’s second engineered T cell therapy programme into the clinic in triple negative breast cancer.

26 Mar 2014

Vigilant announces completion of $2 million oversubscribed Series A financing

Vigilant Biosciences, Inc., developer of the "rinse and spit" test for assessing early risk of oral cancer, today announced the successful completion of a $2.0 million, oversubscribed Series A financing. The company received $2.3 million in total proceeds, including a $300,000 loan from the Florida Institute for the Commercialization of Public Research Seed Capital Acceleration Program.

25 Mar 2014

Women with BRCA1 mutations may have increased risk for rare types of aggressive uterine cancer

Women with BRCA1 mutations may have an increased risk for developing rare types of aggressive uterine cancer despite having their ovaries and fallopian tubes removed, suggest preliminary findings being presented at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer in Tampa, Fla., March 22-25.

25 Mar 2014

Scientist receives $275,000 grant to study human papillomavirus that causes head and neck cancer

Basic scientists focus on understanding how things work, so most don't get the chance to directly impact other people's lives. That's why Michelle Ozbun, PhD, is very excited about her recent grant to study human papillomavirus.

25 Mar 2014

Faster DNA sequencing techniques more likely to improve care for patients with breast cancer

Faster and cheaper DNA sequencing techniques will likely improve care for patients with breast cancer but also create challenges for clinicians as they counsel patients on their treatment options.

25 Mar 2014

Cancer Treatment News and Research

SU2C and Farrah Fawcett announce formation of research team dedicated to HPV-related cancers

Magnetic nanoparticle (mNP) hyperthermia in breast cancer treatment

Women who had radiotherapy for breast cancer may have increased risk of lung tumour

Staying disease-free improves dramatically for ovarian cancer patients

BMC joins SCCA Network, becomes tenth affiliate in the greater Northwest

Concord Medical to establish cancer hospital in Shanghai New Hongqiao International Medical Center

Magnetically controlled nanoparticles force tumour cells to 'self-destruct', shows research

Surgeons use Cyberknife robotic device for treatment of vocal cord cancer

Inhibiting cancer-promoting prolactin causes unconventional cell death in preclinical research

Scientists battle against cancer with nanoballoons and lasers

Dartmouth aims to remove barriers for pancreatic cancer photodynamic therapy

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

MD Anderson's Jim Allison honored with 2014 Canada Gairdner International Award

Study: Sexual dysfunction common with lung cancer

Journal addresses impact of obesity on gynecologic cancer patients

Adaptimmune awarded £2.1 million grant to expedite development of engineered T cell therapy

Vigilant announces completion of $2 million oversubscribed Series A financing

Women with BRCA1 mutations may have increased risk for rare types of aggressive uterine cancer

Scientist receives $275,000 grant to study human papillomavirus that causes head and neck cancer

Faster DNA sequencing techniques more likely to improve care for patients with breast cancer

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News